Repare Therapeutics Inc. (RPTX)
1.19
0.04 (3.48%)
At close: Jan 30, 2025, 3:59 PM
1.19
0.00%
After-hours Jan 30, 2025, 04:00 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| PE Ratio | -3.28 | -21.23 | -7.46 | -23.7 | -41.5 | -34.05 | -62.38 |
| PS Ratio | 6.01 | 4.68 | 104.95 | 9.38K | n/a | n/a | n/a |
| PB Ratio | 1.45 | 2.21 | 2.77 | 4.41 | -24.48 | -21.73 | n/a |
| P/FCF Ratio | -2.38 | -2.20K | -9.12 | -152.12 | -57.23 | -36.84 | -67.9 |
| P/OCF Ratio | -2.42 | 1.92K | -9.3 | -208.05 | -61.28 | -38.54 | -80.96 |
| OCF/S Ratio | -2.49 | 0.00 | -11.29 | -45.07 | n/a | n/a | n/a |
| Debt / Equity Ratio | 0.02 | 0.02 | 0.03 | 0.01 | -0.02 | -0.11 | n/a |
| Quick Ratio | 6.24 | 4.54 | 10.01 | 31.46 | 23.22 | 6.32 | n/a |
| Current Ratio | 6.24 | 4.50 | 10.01 | 31.46 | 23.22 | 6.32 | n/a |
| Asset Turnover | 0.20 | 0.36 | 0.02 | 0.00 | n/a | n/a | n/a |
| Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Return on Equity (ROE) | -0.44 | -0.1 | -0.37 | -0.19 | 0.59 | 0.64 | n/a |
| Return on Assets (ROA) | -0.37 | -0.08 | -0.29 | -0.15 | -0.27 | -1.03 | n/a |
| Return on Capital (ROIC) | -0.54 | -0.07 | -0.33 | -0.16 | -0.27 | -1.07 | n/a |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | -156.59% | 96.83% | 56.00% | -1.22K% | n/a | n/a | n/a |
| Net Profit Margin | -183.44% | -22.03% | -1.41K% | -39.57K% | n/a | n/a | n/a |
| Pretax Profit Margin | -201.79% | -10.54% | -1.43K% | -40.55K% | n/a | n/a | n/a |
| Operating Profit Margin | -227.3% | -15.02% | -1.43K% | -40.22K% | n/a | n/a | n/a |
| FCF Margin | -252.47% | -0.21% | -1.15K% | -6.16K% | n/a | n/a | n/a |
| EBITDA Margin | -223.48% | -13.52% | -1.41K% | -39.56K% | n/a | n/a | n/a |